Literature DB >> 12352818

Selective antibiotic use to prevent postoperative wound infection after external dacryocystorhinostomy.

Bulent Yazici1, Dale R Meyer.   

Abstract

PURPOSE: The use of systemic antibiotic prophylaxis in lacrimal drainage surgery is controversial. Some studies have reported high rates of postoperative infection and surgical failure after lacrimal drainage surgery when systemic antibiotic prophylaxis was not routinely administered. Many ophthalmologists have traditionally used antibiotics only in selected patients undergoing dacryocystorhinostomy (DCR), and this study evaluates the success of this strategy.
METHODS: This was a retrospective interventional case series of 138 consecutive patients who underwent 163 external DCR procedures. Antibiotics were given only when inflammatory signs were present in the medial canthal region or when purulent material was noted during surgery. Patients with persistent external medial canthal inflammatory signs received amoxicillin/clavulanate or cephalexin orally 3 to 7 days before and 1 week after surgery. Patients in whom purulent lacrimal sac material was noted during surgery received cefazolin intravenously.
RESULTS: Postoperative results were evaluated in terms of wound infection and related complications and surgical success. Systemic antibiotics were given in 15 of 163 (9%) cases. Nine (6%) cases received intraoperative (intravenous) antibiotics; 5 (3%) cases received perioperative (oral) antibiotics; and 1 (1%) case received both. None of the patients had postoperative deep soft tissue infection (cellulitis). Skin changes compatible with superficial wound infection occurred in 2 (1%) cases and responded well to topical treatment. Surgery was successful in 157 of 163 (96%) cases. Of 6 failures, none were associated with postoperative wound infection.
CONCLUSIONS: Selective use of antibiotics limited to patients with signs of lacrimal sac inflammation appears sufficient to prevent soft tissue infection after DCR.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12352818     DOI: 10.1097/00002341-200209000-00003

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  4 in total

1.  Surgical Antimicrobial Prophylaxis in Patients of Neonatal and Pediatric Age Subjected to Eye Surgery: A RAND/UCLA Appropriateness Method Consensus Study.

Authors:  Sonia Bianchini; Chiara Morini; Laura Nicoletti; Sara Monaco; Erika Rigotti; Caterina Caminiti; Giorgio Conti; Maia De Luca; Daniele Donà; Giuseppe Maglietta; Laura Lancella; Andrea Lo Vecchio; Giorgio Marchini; Carlo Pietrasanta; Nicola Principi; Alessandro Simonini; Elisabetta Venturini; Rosa Longo; Elena Gusson; Domenico Boccuzzi; Luca Vigo; Fabio Mosca; Annamaria Staiano; Susanna Esposito
Journal:  Antibiotics (Basel)       Date:  2022-04-22

2.  The Role of Topical Antibiotic Prophylaxis in Oculofacial Plastic Surgery: A Randomized Controlled Study.

Authors:  Davin C Ashraf; Oluwatobi O Idowu; Qinyun Wang; Tak YeEun; Thomas S Copperman; Sombat Tanaboonyawat; Benjamin F Arnold; Catherine E Oldenburg; M Reza Vagefi; Robert C Kersten
Journal:  Ophthalmology       Date:  2020-07-19       Impact factor: 12.079

3.  Oral versus single intravenous bolus dose antibiotic prophylaxis against postoperative surgical site infection in external dacryocystorhinostomy for primary acquired nasolacrimal duct obstruction - A randomized study.

Authors:  Jenil Sheth; Suryasnata Rath; Devjyoti Tripathy
Journal:  Indian J Ophthalmol       Date:  2019-03       Impact factor: 1.848

4.  Comparison of the effect of W-shaped and linear skin incisions on scar visibility in bilateral external dacryocystorhinostomy.

Authors:  Metin Ekinci; Halil Hüseyin Caǧatay; Gokcen Gokce; Erdinç Ceylan; Sadullah Keleş; Ozgür Cakici; Mehmet Ersin Oba; Zeliha Yazar
Journal:  Clin Ophthalmol       Date:  2014-02-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.